MLYS · Mineralys Therapeutics, Inc.
Market Cap
$2.49B
Shares
88.41M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1933414
CUSIP
603170101
13F (30d)
170 filings
169 filers
Visit website
Investor relations